Evaluation and initial management of cyanotic heart disease in the newborn

©2010 UpToDate Print | Back Evaluation and initial management of cyanotic heart disease in the newborn Authors Robert L Geggel, MD Laurie B Armsby, MD Section Editors David R Fulton, MD Joseph A Garcia-Prats, MD Deputy Editor Melanie S Kim, MD Last literature review version 18.2: May 2010 | This topic last updated: May 2, 2007 (More) INTRODUCTION — Cyanotic lesions comprise approximately one-third of potentially fatal forms of congenital heart disease (CHD) [1,2]. Early recognition, emergent stabilization, and transport to an appropriate cardiac care center are critically important in the outcome of newborns with these lesions.